345 related articles for article (PubMed ID: 11243747)
21. Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy.
Jubault V; Pacanowski J; Rabian C; Viard JP
Ann Med Interne (Paris); 2000 May; 151(3):163-8. PubMed ID: 10896967
[TBL] [Abstract][Full Text] [Related]
22. The safety of pyrimethamine and sulfadoxine for the prevention of Pneumocystis carinii pneumonia.
Teira R; Virosta M; Muñoz J; Zubero Z; Santamaría JM
Scand J Infect Dis; 1997; 29(6):595-6. PubMed ID: 9580544
[TBL] [Abstract][Full Text] [Related]
23. A controlled trial of dapsone versus pyrimethamine-sulfadoxine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in patients with AIDS.
Payen MC; De Wit S; Sommereijns B; Clumeck N
Biomed Pharmacother; 1997; 51(10):439-45. PubMed ID: 9863502
[TBL] [Abstract][Full Text] [Related]
24. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G
AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054
[TBL] [Abstract][Full Text] [Related]
25. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
Podzamczer D; Salazar A; Jiménez J; Consiglio E; Santín M; Casanova A; Rufí G; Gudiol F
Ann Intern Med; 1995 May; 122(10):755-61. PubMed ID: 7717598
[TBL] [Abstract][Full Text] [Related]
26. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
27. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F
Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164
[TBL] [Abstract][Full Text] [Related]
29. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
González-García J; Rubio García R; Antela López A; García Alcaide F
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
[TBL] [Abstract][Full Text] [Related]
30. Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group.
Leport C; Chêne G; Morlat P; Luft BJ; Rousseau F; Pueyo S; Hafner R; Miro J; Aubertin J; Salamon R; Vildé JL
J Infect Dis; 1996 Jan; 173(1):91-7. PubMed ID: 8537688
[TBL] [Abstract][Full Text] [Related]
31. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
[TBL] [Abstract][Full Text] [Related]
32. Central nervous system toxoplasmosis in adult Ethiopians.
Amogne W; Teshager G; Zenebe G
Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372
[TBL] [Abstract][Full Text] [Related]
33. Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
Podzamczer D; Miró JM; Ferrer E; Gatell JM; Ramón JM; Ribera E; Sirera G; Cruceta A; Knobel H; Domingo P; Polo R; Leyes M; Cosin J; Fariñas MC; Arrizabalaga J; Martínez-Lacasa J; Gudiol F
Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):89-95. PubMed ID: 10746493
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
[TBL] [Abstract][Full Text] [Related]
35. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients.
Foot AB; Garin YJ; Ribaud P; Devergie A; Derouin F; Gluckman E
Bone Marrow Transplant; 1994 Aug; 14(2):241-5. PubMed ID: 7994239
[TBL] [Abstract][Full Text] [Related]
36. Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
Ribera E; Fernandez-Sola A; Juste C; Rovira A; Romero FJ; Armadans-Gil L; Ruiz I; Ocaña I; Pahissa A
Clin Infect Dis; 1999 Dec; 29(6):1461-6. PubMed ID: 10585796
[TBL] [Abstract][Full Text] [Related]
37. Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.
Mussini C; Pezzotti P; Antinori A; Borghi V; Monforte Ad; Govoni A; De Luca A; Ammassari A; Mongiardo N; Cerri MC; Bedini A; Beltrami C; Ursitti MA; Bini T; Cossarizza A; Esposito R;
Clin Infect Dis; 2003 Mar; 36(5):645-51. PubMed ID: 12594647
[TBL] [Abstract][Full Text] [Related]
38. [The impact of the prevention of cerebral toxoplasmosis].
Katlama C
J Neuroradiol; 1995 Sep; 22(3):193-5. PubMed ID: 7472536
[TBL] [Abstract][Full Text] [Related]
39. Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.
Chirgwin K; Hafner R; Leport C; Remington J; Andersen J; Bosler EM; Roque C; Rajicic N; McAuliffe V; Morlat P; Jayaweera DT; Vilde JL; Luft BJ
Clin Infect Dis; 2002 May; 34(9):1243-50. PubMed ID: 11941551
[TBL] [Abstract][Full Text] [Related]
40. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Tocchetti A; Tambini R; Allegro A; Longoni E; Rinaldi E
AIDS; 1994 Feb; 8(2):272-4. PubMed ID: 8043236
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
